CEBPA and neoplasm: In addition, TRIB2 regulates the WNT, YAP and C/EBPα pathways in hepatic cancer 53 and C/EBPα in a model of non‐small‐cell lung cancer 54, as well as possessing complex oncogenic/tumour‐suppressive outputs in the aetiology of AML and ALL 55, 56.